Paper Information

Journal:   JOURNAL OF BIRJAND UNIVERSITY OF MEDICAL SCIENCES   FALL 2010 , Volume 17 , Number 3 (44); Page(s) 149 To 158.
 
Paper: 

EFFECTS OF ω3 FATTY ACID SUPPLEMENT ON ANEMIA AND HEMATOLOGIC FACTORS IN HEMODIALYSIS PATIENTS

 
 
Author(s):  KOOSHKI A.*, TALEBAN F.A., TABIBI H.
 
* DEPARTMENT OF NUTRITION, SCHOOL OF NUTRITION AND FOOD TECHNOLOGY SABZEVAR UNIVERSITY OF MEDICAL SCIENCES, MASHHAD, IRAN
 
Abstract: 

Background and Aim: Anemia is one of the major risk factors for cardiovascular disease (CVD) in hemodialyzed patients. Therefore, the present study was designed to investigate the effects of w3 fatty acid supplement on anemia and hematologic factors in hemodialysis patients.
Materials and Methods: The study was a double-blind randomized clinical trial on 34 hemodialysis patients. The patients in the
w3 fatty acid supplement group received 2080 mg w3 fatty acid daily for 10 weeks while the placebo group received placebo for the same period. At baseline and the end of 10th week of the study, blood hemoglobin, hematocrit, red blood cells, MCV, MCH, MCHC and serum CRP were
measured. Statistical analysis of the data was performed using chi-square, t-test, paired t-test and ANOVA.
Results: The mean age and duration of dialysis were 50
±18 years and 23±25 months in the w3 fatty acid group and 50±17 years and 28±18 months in the placebo group, respectively. During this study, no significant difference was observed between the two groups in mean changes of blood hemoglobin,  hematocrit, red blood cells, MCV, MCH, MCHC and serum CRP.
Conclusion: The results of the present study indicate that
w3 fatty acid supplement has no effect on hematologic factors and anemia in hemodialysis patient.

 
Keyword(s): ω3 FATTY ACID, HEMODIALYSIS, HEMATOLOGIC FACTORS, ANEMIA
 
References: 
  • ندارد
 
  Persian Abstract Yearly Visit 55
 
Latest on Blog
Enter SID Blog